PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
June 30, 2011 | ISSUE NUMBER 206 VOL 8

Pharma Faceoff
Should Pharma Search for External Drug Candidates
Or Develop Internal R&D?

Shire’s Renee Cohen, Sanofi’s Ray Jupp, and Deutsche Bank’s Barbara Ryan are among the experts discussing this question in our latest episode of Pharma Faceoff ...Click to watch

R&D
Planning Beyond the Petri Dish: The Case of Pfizer's Crizotinib
Pfizer's crizotinib development program combined organization, art, and science—and a large dose of unforeseen risk ...Read more

Advertisement
Streamline production, increase cash flow, and minimize risk in your Order to Cash, Contracts, Chargebacks and Compliance processes.
Owens Minor Healthcare Logistics and CDC Software address the pains, the capabilities needed and results possible in these 4 "C" processes. Looking to upgrade your business solution? Get tips for making your buy, subscribe or outsourcing decision. Register Free!

Regulatory
Social Media Guidelines Are DDMAC's 'Highest Priority'
Tom Abrams, director of FDA's Division (soon to be Office) of Drug Marketing, Advertising & Communications (DDMAC), announces that the Division's document on social media guidelines will be "published as soon as it's vetted" ...Read more

Advertisement
Take Control of Your Contracts and Chargebacks Now
New products, growing partner base, high transaction volumes and stringent data accuracy requirements can make managing contracts and chargebacks extremely difficult. Integrated, automated contracts and chargebacks solutions can positively impact sales, operations, purchasing, accounting and customer service. By eliminating unauthorized deductions, minimizing revenue losses and reducing manpower, you can focus on growing your business. Download Now

Leadership
Pharma's Greatest Influencers
We'd like your thoughts on the individuals and institutions that have had the most impact on pharma in the last 30 years ...Read more

Advertisement
Join Pharma Faceoff as we debate the challenges of research & development. Should pharma search for external drug candidates to refill the pipeline or develop internal R&D capabilities? Click here

Global
Europe: New Vision, Old Ideas
The European industry is making saintly noises about collaboration, but vestiges of the old dogma remain, says Reflector, our EU correspondent ...Read more

// Jan Thompson joined Advanstar Communications as VP of Marketing for the Life Sciences Groups, where she assumes marketing responsibility for Healthcare, Pharmaceutical, and CBI. // Roche (Basel, Switzerland) has appointed James Cassidy, MD, PhD, as the Head of Translational Medicine in Oncology Discovery and Translational Area in Pharma Research and Early Development, effective July 1. He will be based in Roche's Nutley, NJ, location. // Ogilvy CommonHealth Worldwide (Parsippany, NJ) announced the promotion of Brad Davidson, PhD, to General Manager of Ogilvy CommonHealth Insights & Analytics. // Kevin Young, Gilead's Executive Vice President for Commercial Operations, has been appointed a CBE by Queen Elizabeth II, in recognition of his "services to the healthcare and pharmaceutical industries, particularly to the development and marketing of life-changing medicines." // INC Research (Raleigh, NC) a therapeutically focused contract research organization, announced that Chris Smyth, PhD, MBA, has joined its oncology leadership team as Senior Vice President, Clinical Development, based in INC Research's European headquarters in Winnersh, UK. //

July 6–7: Social Media in the Pharmaceutical Industry
London, UK

Sept. 20–21: Strategic Pipeline Planning and Resource Allocation Summit
Philadelphia, PA

Sept. 26–27: Pharma/Bio Forum on Preclinical Development
Boston, MA


 
FindPharma  
Search  

 
 
 
Survey
Which emerging market is your company most interested in?
Click To Vote
 
Quick Links

Podcast: Interview with Chris Garabedian. CEO, AVI Biopharma

The Challenges of Developing Anti-Smoking Drugs

Study Points to Dramatic Drop in R&D Expenditure


Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook

User Management
| Subscribe | Update My Profile | Send Feedback | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

 
Visit Pharmaceutical Executive